ADVERTISEMENT
A red sign that reads “Clinical Center, Building 10” outside of a brick building
NIH Fails to Enforce Rules for Reporting Clinical Trial Results
A review by the US Office of Inspector General found that only about half of the scientists running clinical trials funded by the NIH in 2019 and 2020 appropriately recorded their findings in a federal database, as is legally required.
NIH Fails to Enforce Rules for Reporting Clinical Trial Results
NIH Fails to Enforce Rules for Reporting Clinical Trial Results

A review by the US Office of Inspector General found that only about half of the scientists running clinical trials funded by the NIH in 2019 and 2020 appropriately recorded their findings in a federal database, as is legally required.

A review by the US Office of Inspector General found that only about half of the scientists running clinical trials funded by the NIH in 2019 and 2020 appropriately recorded their findings in a federal database, as is legally required.

NIH, clinical trials

EXCLUSIVE
Colorful pills and capsules on a calendar background
Clinical Trial Registry Errors Undermine Transparency
Catherine Offord | Aug 2, 2022 | 10 min read
A lack of comprehension among some researchers about how to use ClinicalTrials.gov may be hindering public access to trial information and holding up drug study results, an investigation by The Scientist finds.
2020 in Scientists’ Own Words
Abby Olena, PhD | Dec 23, 2020 | 5 min read
The world was rocked by the COVID-19 pandemic this year, but researchers rose to all manner of challenges.
A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
Jef Akst | Oct 8, 2020 | 9 min read
Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.
Judge Rules Unreported Clinical Trial Data Must Be Made Public
Amy Schleunes | Feb 26, 2020 | 2 min read
The sponsors of upwards of 1,000 clinical trials may be forced to publish data that have gone unpublished over a 10-year period.
The NIH Loosens Grip on Gene Therapy Trials
Kerry Grens | Aug 16, 2018 | 2 min read
The agency proposes ceding its scrutiny of these studies to the FDA.
NIH’s New Rules Governing Human Research Go Into Effect
Jim Daley | Jan 25, 2018 | 2 min read
More than 3,500 scientists had signed an open letter to NIH Director Francis Collins opposing the rules change.
Opinion: Token Pharmacovigilance
Peter Doshi | May 23, 2017 | 3 min read
A US government website for collecting reports of side effects associated with vaccines is broken. Why has no one noticed?
Marijuana Research Still Stymied by Federal Laws
Bob Grant | Jan 23, 2017 | 5 min read
US scientists continue to have a hard time getting funding to study the health impacts of the drug. But cannabis research in Canada—where medical marijuana is legal nationwide—is different story.
Feds Demand More Clinical Trial Reporting
Kerry Grens | Sep 19, 2016 | 2 min read
Expanded US Health and Human Services rules will require the results of more human studies to be made public.
Two NIH Labs Cease Reagent Production
Kerry Grens | Apr 20, 2016 | 1 min read
Contamination concerns at cell therapy and radioactive tracer facilities spur production shutdowns.
NIH Halts Drug Production
Tracy Vence | Jun 8, 2015 | 1 min read
The National Institutes of Health’s Pharmaceutical Development Section temporarily suspends production following contamination issues.
Spinoff Company to Develop Rare Disease Drugs
Molly Sharlach | Jan 7, 2015 | 2 min read
Maryland-based Vtesse will work with the US National Institutes of Health to advance treatments for Niemann-Pick Type C disease and other lysosomal storage disorders.
Ebola Update
Molly Sharlach | Dec 11, 2014 | 3 min read
NIH admits new patient; joint pains stall clinical trial; U.S. grants immunity to vaccine developers; more
Ebola Vaccine Candidate Shows Promise
Molly Sharlach | Dec 1, 2014 | 2 min read
An experimental Ebola vaccine developed by the US National Institutes of Health appears to be safe and effective, according to a small, early-stage clinical trial.
Push For Data Disclosure
Kerry Grens | Nov 21, 2014 | 2 min read
Two federal health agencies released proposed rules that would tighten the requirements for reporting clinical trial results.
NIH Cleared of Tampering with Ethics Probe
Bob Grant | Sep 18, 2014 | 2 min read
Government auditors absolve the National Institutes of Health of wrongdoing in the case of its involvement in an ethics investigation of a study involving premature babies.
NIH To Speed Ebola Vax Trials
Jef Akst | Sep 2, 2014 | 2 min read
The ongoing Ebola outbreak has prompted the National Institutes of Health to accelerate human trials of multiple Ebola vaccines, starting this week.
NIH Accused of Interfering with Ethics Probe
Bob Grant | May 21, 2014 | 2 min read
A watchdog group claims that the federal agency improperly influenced the investigation of a study involving the treatment of preterm infants.
Opinion: Translational Biotechnology
John D. Loike and Jennifer E. Miller | Feb 17, 2014 | 4 min read
Regulators must consider both the promise and potential pitfalls of new technologies when determining whether to move them into clinical trials.
ADVERTISEMENT